Showing results (171-180 of 218) with videos related to
Sort By:
Pageof 22
Cancer Discovery|September 1, 2022
Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing CohortKanika Arora, Thinh N Tran, Yelena Kemel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 TherapyJarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2019
Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLCScott J Antonia, Ani Balmanoukian, Julie Brahmer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2018
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation SequencingHira Rizvi, Francisco Sanchez-Vega, Konnor La, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2019
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancerK Hastings, H A Yu, W Wei, et al.Cancer Immunology Research|December 18, 2023
Immune-Related Colitis Is Associated with Fecal Microbial Dysbiosis and Can Be Mitigated by Fecal Microbiota TransplantationArielle Elkrief, Nicholas R Waters, Natalie Smith, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 21, 2020
COVID-19 in patients with lung cancerJ Luo, H Rizvi, I R Preeshagul, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung CancerJiajia Zhang, Zhicheng Ji, Justina X Caushi, et al.European Journal of Cancer (Oxford, England : 1990)|May 22, 2021
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamicsLaura Mezquita, Isabel Preeshagul, Edouard Auclin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2024
Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non-Small-Cell Lung CancerArielle Elkrief, Meagan Montesion, Smruthy Sivakumar, et al.Pageof 22